Patched 2 (PTCH2) inhibitors belong to a class of chemical compounds designed to selectively target and modulate the activity of the Patched 2 protein. PTCH2 is a transmembrane receptor and a crucial component of the Hedgehog (Hh) signaling pathway, which plays a fundamental role in embryonic development, tissue repair, and adult tissue homeostasis. This pathway involves the regulation of genes responsible for cell proliferation, differentiation, and tissue patterning. PTCH2 serves as a receptor for the Hh ligands, primarily Sonic Hedgehog (Shh), and plays a pivotal role in the control of downstream signaling events. PTCH2 inhibitors are developed through chemical synthesis and structural optimization techniques, with the primary goal of interacting with specific domains or functional motifs of the PTCH2 protein to influence its cellular functions.
The design of PTCH2 inhibitors typically involves creating molecules that can selectively bind to PTCH2, potentially disrupting its interactions with Hh ligands or modulating its downstream signaling activities. By modulating PTCH2 activity, these inhibitors can potentially impact the transduction of Hh signaling, affecting cellular processes such as cell fate determination, tissue growth, and regeneration. The study of PTCH2 inhibitors provides valuable insights into the intricate molecular mechanisms governing embryonic development and tissue homeostasis, offering a deeper understanding of the fundamental processes that underlie tissue patterning and regeneration. This research advances our knowledge of basic developmental biology and the regulatory networks that control tissue development and repair.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
An inhibitor of the Smoothened (SMO) protein in the Hh pathway, cyclopamine might indirectly affect PTCH2 expression. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
A SMO antagonist, vismodegib is used to inhibit Hh signaling and could potentially influence PTCH2 expression. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
Another SMO inhibitor, sonidegib targets the Hh pathway and might indirectly affect PTCH2 expression. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $64.00 $131.00 $204.00 | 6 | |
An inhibitor of GLI transcription factors in the Hh pathway, GANT61 could indirectly modulate PTCH2 expression. | ||||||
Saridegib | 1037210-93-7 | sc-507351 | 5 mg | $3500.00 | ||
A potent SMO inhibitor, saridegib targets Hh signaling and could impact PTCH2 expression. | ||||||
Jervine | 469-59-0 | sc-200934 sc-200934A | 1 mg 5 mg | $66.00 $240.00 | 1 | |
Structurally similar to cyclopamine, jervine inhibits Hh signaling and might influence PTCH2 expression. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Known as an antifungal, itraconazole also inhibits SMO and could influence Hh pathway components like PTCH2. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Impacts SHH signaling and might have an indirect effect on PTCH2 expression. | ||||||
Robotnikinin | 1132653-79-2 | sc-396554 | 1 mg | $650.00 | 1 | |
A small molecule that inhibits SHH protein, potentially affecting downstream targets like PTCH2. | ||||||